[go: up one dir, main page]

DE60336417D1 - Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen - Google Patents

Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen

Info

Publication number
DE60336417D1
DE60336417D1 DE60336417T DE60336417T DE60336417D1 DE 60336417 D1 DE60336417 D1 DE 60336417D1 DE 60336417 T DE60336417 T DE 60336417T DE 60336417 T DE60336417 T DE 60336417T DE 60336417 D1 DE60336417 D1 DE 60336417D1
Authority
DE
Germany
Prior art keywords
nonanese
treatment
liquid compositions
arrhythmic events
arrhythmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336417T
Other languages
English (en)
Inventor
Johannes Wilhelmus Jansen
Vries Michiel Henricus De
Werner Cautreels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Abbott Products GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products GmbH filed Critical Abbott Products GmbH
Application granted granted Critical
Publication of DE60336417D1 publication Critical patent/DE60336417D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE60336417T 2002-11-18 2003-11-17 Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen Expired - Lifetime DE60336417D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42679502P 2002-11-18 2002-11-18
PCT/EP2003/012844 WO2004045591A2 (en) 2002-11-18 2003-11-17 Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events

Publications (1)

Publication Number Publication Date
DE60336417D1 true DE60336417D1 (de) 2011-04-28

Family

ID=32326429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336417T Expired - Lifetime DE60336417D1 (de) 2002-11-18 2003-11-17 Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen

Country Status (20)

Country Link
US (2) US7087620B2 (de)
EP (1) EP1565239B8 (de)
JP (1) JP2006510613A (de)
KR (1) KR101059330B1 (de)
CN (1) CN1726062A (de)
AR (1) AR042199A1 (de)
AT (1) ATE501758T1 (de)
AU (1) AU2003296580B8 (de)
BR (1) BR0316383A (de)
CA (1) CA2506083A1 (de)
DE (1) DE60336417D1 (de)
IL (1) IL168630A (de)
MX (1) MXPA05005344A (de)
NO (1) NO20053010L (de)
RU (1) RU2358732C2 (de)
SA (1) SA04250023B1 (de)
TW (1) TW200418468A (de)
UA (1) UA85546C2 (de)
WO (1) WO2004045591A2 (de)
ZA (1) ZA200504049B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
WO2005011690A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2007023775A1 (ja) * 2005-08-23 2007-03-01 Astellas Pharma Inc. 心房細動治療剤
EP2149370A1 (de) * 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabizyclischen Verbindungen und Mikroemulsionen, dieselben enthaltend

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3361244D1 (de) * 1982-01-29 1986-01-02 Ici Plc Alkanolamine derivatives
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4402931A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
US5576349A (en) * 1995-11-30 1996-11-19 The General Hospital Corporation Retionoic acid treatment of cardiac arrhythmia
US6026817A (en) * 1996-11-14 2000-02-22 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US6790463B2 (en) * 2001-03-30 2004-09-14 Robert F. Hofmann Uses of targeted oxidative therapeutic formulation in arteriosclerosis
DE10131217A1 (de) * 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events

Also Published As

Publication number Publication date
CA2506083A1 (en) 2004-06-03
JP2006510613A (ja) 2006-03-30
RU2005119280A (ru) 2006-03-20
US20050261300A1 (en) 2005-11-24
MXPA05005344A (es) 2005-08-03
AU2003296580B2 (en) 2010-02-18
KR20050116125A (ko) 2005-12-09
AU2003296580A1 (en) 2004-06-15
US7087620B2 (en) 2006-08-08
NO20053010L (no) 2005-06-20
AU2003296580B8 (en) 2010-03-18
SA04250023B1 (ar) 2008-12-23
US20040152716A1 (en) 2004-08-05
ZA200504049B (en) 2006-07-26
BR0316383A (pt) 2005-10-04
CN1726062A (zh) 2006-01-25
TW200418468A (en) 2004-10-01
EP1565239A2 (de) 2005-08-24
RU2358732C2 (ru) 2009-06-20
IL168630A (en) 2013-08-29
UA85546C2 (en) 2009-02-10
KR101059330B1 (ko) 2011-08-24
ATE501758T1 (de) 2011-04-15
EP1565239B1 (de) 2011-03-16
WO2004045591A3 (en) 2004-07-22
WO2004045591A2 (en) 2004-06-03
EP1565239B8 (de) 2011-06-22
AR042199A1 (es) 2005-06-15

Similar Documents

Publication Publication Date Title
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
EP1534074A4 (de) Kombinationstherapie zur behandlung von fettleibigkeit
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
DE69925865D1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE602004022153D1 (de) Verbindungen zur behandlung von obesitas
ATE381938T1 (de) Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60336417D1 (de) Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen